Novo’s shares plunged on Thursday after telehealth firm Hims & Hers Health Inc. launched a cheaper copycat version of its Wegovy pill that the Danish drugmaker says is illegal. Michael Shah of Bloomberg Intelligence has more. (Source: Bloomberg)